Ecuadorian scientists are developing a biotechnological strategy to stop banana wilt by genetically editing the causative ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

Analysts expect PDS Biotechnology to report an earnings per share (EPS) of $-0.20. PDS Biotechnology bulls will hope to hear ...

Pds Biotechnology (($PDSB)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call of PDS ...

ValGenesis has a two-decade history of innovation in life sciences technology. In 2005, the company introduced the world's first digital validation lifecycle management system-a breakthrough that ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

Pds Biotechnology ( ($PDSB) ) has released its Q3 earnings. Here is a breakdown of the information Pds Biotechnology presented to its investors.

Picture a world where most life-saving medicines are discovered not in the United States, but in Beijing and Shanghai. Imagine a time when the most advanced biotechnologies, therapies that cure ...

Puma Biotechnology has one approved drug, strong cash, and is developing alisertib with key ALISCA trial readouts in 1H 2026.

A global biotechnology company with roots in the Capital Region is expanding into Saratoga County with a new facility.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...